5DK3

Crystal Structure of Pembrolizumab, a full length IgG4 antibody


Sequence Similarity Clusters for the Entities in PDB 5DK3

Entity #1 | Chains: A,F
Light Chain protein, length: 218 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 2 3 16616
95 % 2 3 17554
90 % 94 296 66
70 % 886 2682 2
50 % 2307 6927 1
40 % 2308 6928 1
30 % 2324 6975 1
Entity #2 | Chains: B,G
Heavy Chain protein, length: 444 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 49389
95 % 1 1 44423
90 % 1 1 42542
70 % 3 10 4684
50 % 4 27 1454
40 % 4 33 1084
30 % 4 33 1144

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 6VI2 1 A, C FAB4 light chain 9606
2 6VI2 2 B, D FAB4 heavy chain 9606
3 4NZU 1 L 13PL heavy chain Fab 9606
4 4NZU 2 H 13PL light chain Fab 9606
5 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
6 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
7 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
8 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
9 1MEX 1 L Fab 29G12 light chain 10090
10 1MEX 2 H Fab 29G12 heavy chain 10090
11 6WFY 1 H Fab224 heavy chain 9606
12 6WFY 2 L Fab224 light chain 9606
13 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
14 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
15 4BUH 1 A, B CLONE M0418 SCFV 9606
16 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
17 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
18 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
19 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
20 6UCF 1 L N123-VRC34_pI4 light chain 9606
21 6UCF 2 H N123-VRC34_pI4 heavy chain 9606
22 5YD4 1 A, C, E, G scFv 4B08 10090
23 5YD3 1 A, C, E, G scFv 4B08 10090
24 6OC7 1 H Heavy chain of HMP42 Fab 9606
25 6OC7 2 L Light chain for HMP42 Fab 9606
26 5UD9 1 H Fab heavy chain 9606
27 5UD9 2 L Light chain 9606
28 4P48 1 A Antibody scFv 180 9031
29 6DDM 1 A Anti-MICA Fab fragment light chain clone 1D5 10090
30 6DDM 3 B Anti-MICA Fab fragment heavy chain clone 1D5 10090
31 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
32 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
33 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
34 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
35 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
36 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
37 6MEE 1 A, C antibody HEPC74 Heavy Chain 9606
38 6MEE 2 B, D antibody HEPC74 Light Chain 9606
39 6BJZ 1 H 5c8 Fab Heavy chain 9606
40 6BJZ 2 L 5c8 Fab Light chain 9606
41 6O3D 1 L PGZL1 FAB LIGHT CHAIN 9606
42 6O3D 2 H PGZL1 FAB HEAVY CHAIN 9606
43 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
44 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
45 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
46 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
47 4XCF 1 L 4E10 Fab light chain 9606
48 4XCF 2 H 4E10 Fab heavy chain 9606
49 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
50 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
51 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
52 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
53 3ESU 1 F Antibody 14b7* light chain and antibody 14b7* heavy chain linked with a synthetic (GGGGS)4 linker 10090
54 6O24 1 A 4498 Fab heavy chain 9606
55 6O24 2 B 4498 Kappa light chain 9606
56 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
57 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
58 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
59 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
60 6UCE 1 L N123-VRC34_pI3 light chain 9606
61 6UCE 2 H N123-VRC34_pI3 heavy chain 9606
62 6Y1L 1 H FAB A.17 L47R mutant HEAVY CHAIN 9606
63 6Y1L 2 L FAB A.17 L47R mutant Light CHAIN 9606
64 5X08 1 H Fab 4E10 Heavy chain 9606
65 5X08 2 L Fab 4E10 Light chain 9606
66 6NB8 1 H S230 antigen-binding (Fab) fragment, heavy chain 9606
67 6NB8 2 L S230 antigen-binding (Fab) fragment, light chain 9606
68 6A76 1 L Light chain of the anti-human Robo1 antibody B5209B Fab 10090
69 6A76 2 H Heavy chain of the anti-human Robo1 antibody B5209B Fab 10090
70 6U1T 1 H antigen-binding (Fab) fragment, heavy chain 10090
71 6U1T 2 L antigen-binding (Fab) fragment, light chain 10090
72 6MEG 1 H antibody HEPC46 Heavy Chain 9606
73 6MEG 2 L antibody HEPC46 Light Chain 9606
74 5C2B 1 H scFv 3B4 9606
75 6O3K 1 L PGZL1.H4K3 light chain 9606
76 6O3K 2 H PGZL1.H4K3 heavy chain 9606
77 4XAW 1 L 4E10 Fab light chain 9606
78 4XAW 2 H 4E10 Fab heavy chain 9606
79 4P49 1 A Antibody scFv B8 9031
80 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
81 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
82 6WG8 1 A Dupilumab Fab heavy chain 9606
83 6WG8 2 B Dupilumab Fab light chain 9606
84 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
85 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
86 6TCR 1 H Omalizumab Fab Ser81Arg, Gln83Arg and Leu158Pro light chain mutant Omalizumab Fab heavy chain 9606
87 6TCR 2 L Omalizumab Fab Ser81Arg, Gln83Arg and Leu158Pro light chain mutant Omalizumab Fab Ser81Arg, Gln83Arg and Leu158Pro light chain mutant 9606
88 5UCB 1 H Fab Heavy Chain 9606
89 5UCB 2 L Fab Light Chain 9606
90 2VXV 1 H HUMAN IGG ABT-325 9606
91 2VXV 2 L HUMAN IGG ABT-325 9606
92 6QF9 1 A, B scFv 9606
93 6FRJ 1 H scFv-SM3 Although this structure is a ScFv, please follow the same numbering as shown in PDB entry 5OWP. 10090
94 4GXV 1 H, I Antibody 1F1, heavy chain 9606
95 4GXV 2 L, M Antibody 1F1, light chain 9606
96 2VXT 1 H MURINE IGG 125-2H 10090
97 2VXT 3 L MURINE IGG 125-2H 10090
98 6CR1 1 L Light chain of adalimumab EFab (VL-IgE CH2) 9606
99 6CR1 2 H Heavy chain of adalimumab EFab (VH-IgE CH2) 9606
100 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
101 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
102 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
103 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
104 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
105 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
106 5W24 1 L 5C4 Fab Light Chain 10090
107 5W24 2 H 5C4 Fab Heavy Chain 10090
108 4HPY 1 H CH59 Fab heavy chain 9606
109 4HPY 2 L CH59 Fab light chain 9606
110 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
111 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
112 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
113 6XMI 1 A, D Fab Light chain 9606
114 6XMI 2 B, E Fab Heavy chain 9606
115 4JG1 1 L Fab light chain 9606
116 4JG1 2 H Fab heavy chain 9606
117 6E65 1 L TB31F Fab light chain 9606
118 6E65 2 H TB31F Fab heavy chain 9606
119 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
120 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
121 5VF2 1 A scFv 2D10 10090
122 5I8C 1 A VRC34.01 Fab heavy chain 9606
123 5I8C 2 B VRC34.01 Fab light chain 9606
124 4O5L 1 L Fab F045-092 light chain 9606
125 4O5L 2 H Fab F045-092 heavy chain 9606
126 5MYX 1 A, C Fab c#24 light chain 10090
127 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
128 3IFL 1 L 12A11 FAB antibody light chain 10090
129 3IFL 2 H 12A11 FAB antibody heavy chain 10090
130 5WK2 1 L M116 LIGHT CHAIN 9606
131 5WK2 2 H M116 HEAVY CHAIN FD 9606
132 3PP4 1 H GA101 Fab heavy chain 10090
133 3PP4 2 L GA101 Fab light chain 10090
134 3KDM 1 A, L Immunoglobulin light chain 9606
135 3KDM 2 B, H Immunoglobulin heavy chain 9606
136 5NIV 1 A Light chain of 5D3 Fab 10090
137 5NIV 2 B Heavy chain of 5D3 Fab 10090
138 6UG7 1 L ch28/11 Fab light chain 10090
139 6UG7 2 H ch28/11 Fab heavy chain 10090
140 5N4J 1 L LIGHT CHAIN 9606
141 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
142 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
143 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
144 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
145 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
146 5X4G 1 A 6H8 Fab heavy chain 10090
147 5X4G 2 B 6H8 Fab light chain 10090
148 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
149 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
150 4PTU 1 A Antibody pn132p2C05, light chain 9606
151 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
152 4TPR 1 L If kappa light chain 10090
153 4TPR 2 H Fab heavy chain 10090
154 6HGU 1 A, H anti-APP-tag Fab heavy-chain 10090
155 6HGU 2 B, L anti-APP-tag Fab light-chain anti-APP-tag Fab heavy-chain 10090
156 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
157 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
158 3IFN 1 H 12A11 FAB antibody heavy chain 10090
159 3IFN 2 L 12A11 FAB antibody light chain 10090
160 5U3P 1 H DH511.4 Fab Heavy Chain 9606
161 5U3P 2 L DH511.4 Fab Light Chain 9606
162 6BLA 1 H AMM01 Fab Heavy chain 9606
163 6BLA 2 L AMM01 Fab Light chain 9606
164 4TOY 1 H 35O22 Fab Heavy chain 9606
165 4TOY 2 L 35O22 Fab Light chain 9606
166 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
167 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
168 3NPS 2 B S4 FAB HEAVY CHAIN 9606
169 3NPS 3 C S4 FAB LIGHT CHAIN 9606
170 5I4F 1 A scFv 2D10 10090
171 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
172 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
173 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
174 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
175 5WN9 1 H scFv 2D10 9606
176 4XC3 1 L 4E10 Fab light chain 9606
177 4XC3 2 H 4E10 Fab heavy chain 9606
178 1X9Q 1 A 4m5.3 anti-fluorescein single chain antibody fragment antibody binding fragment 9606
179 4M5Y 1 H, I Fab 5J8 heavy chain 9606
180 4M5Y 2 L, M Fab 5J8 light chain 9606
181 4TQE 1 L If kappa light chain 10090
182 4TQE 2 H Fab heavy chain 10090
183 5YY4 1 A scFv 4B08 10090
184 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
185 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
186 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
187 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
188 6Q19 1 L Fab lambda chain 9606
189 6Q19 2 H Fab heavy chain 9606
190 6PDR 1 L antibody vFP25.18 light chain 10090
191 6PDR 2 H antibody vFP25.18 heavy chain 10090
192 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
193 5VSI 2 L CH1/Ckappa Fab light chain 9606
194 6NUY 1 L antibody M86 Fab arm light chain 10090
195 6NUY 2 H antibody M86 Fab arm heavy chain 10090
196 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
197 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
198 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
199 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
200 5JXA 1 H VRC03 Heavy chain 9606
201 5JXA 2 L VRC03 Light chain 9606
202 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
203 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
204 6QCU 1 L Light chain 9606
205 6QCU 2 H Heavy chain 9606
206 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
207 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
208 3NTC 1 L Fab light chain 10090
209 3NTC 2 H Fab heavy chain 10090
210 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
211 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
212 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
213 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
214 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
215 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
216 6PBV 1 A, C Fab668 light chain 9606
217 6PBV 2 B, D Fab668 heavy chain 9606
218 6PZG 1 L NA-80 Fab light chain 9606
219 6PZG 2 H NA-80 Fab heavy chain 9606
220 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
221 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
222 6BE3 1 H Fab (F598) Heavy Chain 9606
223 6BE3 2 L Fab (F598) Light Chain 9606
224 4NWU 1 H APE1551 Ab Fab heavy chain 9606
225 4NWU 2 L APE1551 Ab Fab light chain 9606
226 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
227 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
228 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
229 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
230 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
231 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
232 5EWI 1 H VRC38.01 Heavy Chain 9606
233 5EWI 2 L VRC38.01 Light Chain 9606
234 6SVL 1 A, D, G, H, K, O Fab_heavy_chain 9606
235 6SVL 2 B, E, I, L, M, P Fab_light_chain 9606
236 5E2W 1 L AT8 LIGHT CHAIN 10090
237 5E2W 2 H AT8 HEAVY CHAIN 10090
238 5MYK 1 A Fab c#17 light chain 10090
239 5MYK 2 B Fab c#17 heavy chain 10090
240 4NZR 1 H PGT135 heavy chain Fab 9606
241 4NZR 2 L PGT135 light chain Fab 9606
242 5MYO 1 A, C Fab c#6 light chain 10090
243 5MYO 2 B, D Fab c#6 heavy chain 10090
244 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
245 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
246 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
247 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
248 5UEL 1 H 354NC102 Fab Heavy Chain 9606
249 5UEL 2 L 354NC102 Fab Light Chain 9606
250 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
251 6WIY 1 H Fab 54-1G05 heavy chain 9606
252 6WIY 2 L Fab 54-1G05 light chain 9606
253 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
254 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
255 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
256 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
257 5E2V 1 L AT8 LIGHT CHAIN 10090
258 5E2V 2 H AT8 HEAVY CHAIN 10090
259 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
260 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
261 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
262 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
263 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
264 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
265 5JUE 1 L light chain of UIC2 Fab 10090
266 5JUE 2 H heavy chain of UIC2 Fab 10090
267 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
268 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
269 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
270 5JR1 1 H 10E8 heavy chain 9606
271 5JR1 2 L 10E8 mature light chain 9606
272 6CA7 1 L PCT64_13C light chain 9606
273 6CA7 2 H PCT64_13C heavy chain 9606
274 5VF6 1 A single chain variable fragment 9031
275 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
276 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
277 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
278 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
279 6K4Z 1 A, B scFv of C6 The fusion protein of expression tags (residues -2-0), the light chain (residues 1-108), linker GGGGSGGGGSGGGGS (residues 501-515), and the heavy chain (residues 1001-1113) 10090
280 6MVL 2 H Antibody Fab fragment heavy chain 9606
281 6MVL 3 L Antibody Fab fragment light chain 9606
282 5OB5 2 H fAb Heavy chain 9606
283 5OB5 3 L fAb Light chain 9606
284 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
285 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
286 5I66 1 A 8B6 antibody, heavy chain 10090
287 5I66 2 B 8B6 antibody, light chain 10090
288 6QBC 1 H Anti-Mcl1 Fab Heavy Chain 9606
289 6QBC 2 L Anti-Mcl1 Fab Light Chain 9606
290 6WG0 1 H Fab366 heavy chain 9606
291 6WG0 2 L Fab366 light chain 9606
292 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
293 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
294 6BZY 1 H 22D11 Heavy Chain 10090
295 6BZY 2 L 22D11 Light Chain 10090
296 3QQ9 1 C, L 101F LIGHT CHAIN 10090
297 3QQ9 2 D, H 101F HEAVY CHAIN 10090
298 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
299 5TKK 3 L mouse antibody vFP5.01 light chain 10090
300 6PLH 1 A Fab 5G12 light chain 10090
301 6PLH 2 B Fab 5G12 heavy chain 10090
302 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
303 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
304 5W6C 1 H UCA Fab heavy chain 9606
305 5W6C 2 L UCA Fab light chain 9606
306 5I1K 1 L FAB LIGHT CHAIN 9606
307 5I1K 2 H FAB HEAVY CHAIN 9606
308 3OZ9 1 L Fab NC-1 kappa light chain 10090
309 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
310 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
311 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
312 5V7U 1 L CBTAU-22.1 Fab light chain 9606
313 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
314 5UEA 1 A, H Fab Heavy Chain 9606
315 5UEA 3 B, L Fab Light Chain 9606
316 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
317 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
318 6LTG 1 A, C antibody Fab fragment H-chain 10090
319 6LTG 2 B, D antibody Fab fragment L-chain 10090
320 3G5Y 1 A 175 light chain 10090
321 3G5Y 2 B 175 heavy chain 10090
322 5NMV 1 L Fab light chain 10088
323 5NMV 2 H Fab heavy chain 10088
324 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
325 4N8C 2 L, M Light chain of monoclonal antibody 10090
326 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
327 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
328 4HGW 1 A Antibody Fab fragment, light chain 10090
329 4HGW 2 B Antibody Fab fragment, heavy chain 10090
330 1NLB 1 L antibody 19D9D6 light chain 10090
331 1NLB 2 H antibody 19D9D6 heavy chain 10090
332 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
333 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
334 3VFG 1 L 3F8 Light Chain 10090
335 3VFG 2 H 3F8 Heavy Chain 10090
336 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
337 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
338 3QRG 1 L Fab light chain 9606
339 3QRG 2 H Fab heavy chain Fd fragment 9606
340 5M6A 1 A, B, C, D Bence-Jones light chain 9606
341 4LLY 1 A, C mutated Pertuzumab Fab heavy chain 9606
342 4LLY 2 B, D light chain Clambda 9606
343 6Y49 1 H A.17kappa antibody FAB fragment - Heavy Chain 9606
344 6Y49 2 L A.17kappa antibody FAB fragment - Light Chain 9606
345 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
346 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
347 5EZI 1 H Fab c12 heavy chain 9606
348 5EZI 2 L Fab c12 Light chain 9606
349 4K23 1 H anti-uPAR antibody, heavy chain 10090
350 4K23 2 L anti-uPAR antibody, light chain 10090
351 3NCJ 1 L Fab15 Mut8 light chain 9606
352 3NCJ 2 H Fab15 Mut8 heavy chain 9606
353 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
354 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
355 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
356 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
357 5W05 1 L M59 FAB LIGHT CHAIN 10090
358 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
359 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
360 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
361 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
362 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
363 4M61 1 A, C Fab A52 light chain 10090
364 4M61 2 B, D Fab A52 heavy chain 10090
365 5YE3 1 B 2A7D9 VH CH1 chain 10090
366 5YE3 2 A 2A7D9 L chain 10090
367 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
368 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
369 1UM5 1 L Antibody 21H3 L chain 10090
370 1UM5 2 H Antibody 21H3 H chain 10090
371 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
372 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
373 4NWT 1 L APE1531 Ab Fab light chain 9606
374 4NWT 2 H APE1531 Ab Fab heavy chain 9606
375 3WHX 1 A mAb Fab H fragment 10090
376 3WHX 2 B mAb Fab L fragment 10090
377 3NA9 1 L Fab15 light chain 9606
378 3NA9 2 H Fab15 heavy chain 9606
379 6Y1K 1 H FAB A.17 L47R mutant Heavy Chain 9606
380 6Y1K 2 L FAB A.17 L47R mutant Light Chain 9606
381 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
382 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
383 6RCO 1 A, C R5.004 heavy chain 9606
384 6RCO 2 B, D R5.004 light chain 9606
385 6VBO 1 L DH813 light chain 9606
386 6VBO 2 H DH813 heavy chain 9606
387 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
388 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
389 4LRI 1 A, B MSL-109 Light Chain 9606
390 4LRI 2 C, P MSL-109 Heavy Chain 9606
391 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
392 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
393 4JN2 1 A, L anti dabigatran Fab 10090
394 4JN2 2 B, H anti dabigatran Fab 10090
395 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
396 4XBE 2 H 4E10 Fab heavy chain 9606
397 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
398 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
399 6BE2 1 H Fab (F598) Heavy Chain 9606
400 6BE2 2 L Fab (F598) Light Chain 9606
401 4JFZ 1 L Fab light chain 9606
402 4JFZ 2 H Fab heavy chain 9606
403 6ARP 1 A, C Cetuximab mutant light chain,Uncharacterized protein 9606
404 6ARP 2 B, D Cetuximab mutant Fab heavy chain,Immunoglobulin gamma-1 heavy chain 9606
405 3WIF 1 A mAb Fab H fragment 10090
406 3WIF 2 B mAb Fab L fragment 10090
407 5U6A 1 A Light Chain 9606
408 5U6A 2 B Heavy Chain 9606
409 6K0Y 1 A Antibody Heavy Chain 9606
410 6K0Y 2 B Antibody Light Chain 9606
411 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
412 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
413 3MBX 1 L X836 LIGHT CHAIN 10090
414 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
415 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
416 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
417 6PXR 1 L BIIB092 Fab (murine), light chain 10090
418 6PXR 2 H BIIB092 Fab (murine), heavy chain 10090
419 6APC 1 H Epididymis luminal protein 214 9606
420 6APC 2 L IGL@ protein 9606
421 6WOS 1 H Fab AR3B heavy chain 9606
422 6WOS 2 L Fab AR3B light chain 9606
423 4HHA 1 A Fab KE5 Fab fragment KE5 9606
424 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
425 6FZQ 1 H scFv-1SM3,scFv-1SM3 10090
426 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
427 4RGO 2 H 14G8 heavy chain Fab 10090
428 4RGO 3 L 14G8 light chain Fab 10090
429 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
430 5GRY 1 A, G diabody 9606
431 5UEK 2 H Fab 12E Heavy Chain 9606
432 5UEK 3 L Fab 12E Light Chain 9606
433 3NAA 1 L Fab15 Mut5 light chain 9606
434 3NAA 2 H Fab15 Mut5 heavy chain 9606
435 1Q0X 1 L Fab 9B1, light chain 10090
436 1Q0X 2 H Fab 9B1, heavy chain 10090
437 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
438 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
439 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
440 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
441 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
442 5IK3 2 B, D 1E03 Fab fragment light chain 9606
443 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
444 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
445 5XLI 1 a, b FabL 10090
446 5XLI 2 c, d FabH 10090
447 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
448 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
449 6DC4 1 H Fab AM22 Heavy Chain 9606
450 6DC4 2 L Fab AM22 Light Chain 9606
451 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
452 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
453 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
454 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
455 4WUK 1 H CH65 heavy chain 9606
456 4WUK 2 L CH65 light chain 9606
457 6WGK 1 A, C, E, G Dupilumab Fab heavy chain 9606
458 6WGK 2 B, D, F, H Dupilumab Fab light chain 9606
459 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
460 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
461 7JMP 2 H COVA2-39 heavy chain 9606
462 7JMP 3 L COVA2-39 light chain 9606
463 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
464 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
465 5JOP 1 D, L Fab 14.22 light chain 10090
466 5JOP 2 E, H Fab14.22 heavy chain 10090
467 4HPO 1 H CH58 Fab heavy chain 9606
468 4HPO 2 L CH58 Fab light chain 9606
469 6VLN 1 H 4498 Fab heavy chain 9606
470 6VLN 2 L 4498 Fab light chain 9606
471 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
472 5UKN 2 L DH522UCA Fab fragment light chain 9544
473 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
474 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
475 5IT2 1 H heavy chain 9606
476 5IT2 2 L light chain 9606
477 6MY4 1 A, H anti-VEGF-A Fab fragment bH1 heavy chain 9606
478 6MY4 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
479 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
480 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
481 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
482 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
483 5KVE 2 L ZV-48 Antibody scFv 10090
484 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
485 5MO3 3 L Fab of monoclonal antibody, light chain 10090
486 6L8T 1 B, D, L Antibody light chain 9606
487 6L8T 2 A, C, H Antibody heavy chain 9606
488 5GZ0 1 A, C FM329 light chain 1383439
489 5GZ0 2 B, D FM329 heavy chain 1383439
490 6DW2 1 A 6078 Fab light chain 9606
491 6DW2 2 B 6078 Fab heavy chain 9606
492 6SS0 1 HHH, III Fab C0021181 heavy chain (IgG1) Amino acids are numbered according to the Kabat numbering scheme. 9606
493 6SS0 2 LLL, MMM Fab C0021181 light chain (IgG1) Amino acids are numbered according to the Kabat numbering scheme. Residue 10 would not be present in the Kabat scheme, but due to problems with non-continuous numbering in L-peptides, we included it. Therefore, residues 2-10 should be read as 1-9, per Kabat. 9606
494 6MG4 1 A, B JTO light chain 9606
495 6BQB 1 L MGG4 Fab light chain 9606
496 6BQB 2 H MGG4 Fab heavy chain 9606
497 4PUB 1 H DX-2930 HEAVY CHAIN 9606
498 4PUB 2 L DX-2930 LIGHT CHAIN 9606
499 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
500 6B14 2 L Light chain of Fab BL3-6S97N 10090
501 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
502 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
503 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
504 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
505 5GS3 1 A, H diabody protein 9606
506 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
507 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
508 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
509 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
510 5VKD 2 H Fab Heavy Chain 9606
511 5VKD 3 L Fab light chain 9606
512 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
513 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
514 5XHG 1 A, C polypeptide(L) 10090
515 5XHG 2 B, D polypeptide(H) 10090
516 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
517 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
518 3UYR 1 H antibody Fab heavy chain 10090
519 3UYR 2 L antibody Fab light chain 10090
520 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
521 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
522 6UOE 1 H 3-25 Fab heavy chain 9606
523 6UOE 2 L 3-25 Fab light chain 9606
524 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
525 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
526 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
527 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
528 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
529 3OAZ 2 K, L Fab 2G12, light chain 9606
530 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
531 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
532 1ZAN 1 L Fab AD11 Light Chain 10116
533 1ZAN 2 H Fab AD11 Heavy Chain 10116
534 6CJK 1 A, C Immunoglobulin Fab light chain 9986
535 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
536 4N0Y 1 H IGH526 Heavy Chain 9606
537 4N0Y 2 L IGH526 Light Chain 9606
538 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
539 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
540 6OTC 2 H sFab H3 heavy chain 32630
541 6OTC 3 L sFab H3 light chain 32630
542 6Q1G 1 L H1244 Fab lambda chain 9606
543 6Q1G 2 H H1244 Fab heavy chain 9606
544 5MTH 1 A, H antibody Fab heavy chain 10090
545 5MTH 2 B, L antibody Fab light chain 10090
546 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
547 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
548 6O26 1 A 3246 Fab heavy chain 9606
549 6O26 2 B 3246 Fab light chain 9606
550 1RZF 1 L Fab E51 light chain 9606
551 1RZF 2 H Fab E51 heavy chain 9606
552 5ZMJ 1 H Heavy chain of a Fab fraction of human IgG P01857 (UniProt) is referred. 9606
553 5ZMJ 2 L Light chain of a Fab fraction of human IgG P0DOY2(UniProt) is referred. 9606
554 6MY5 1 A, H anti-VEGF-A Fab fragment bH1 heavy chain 9606
555 6MY5 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
556 6WJ0 1 H Fab 54-4H03 heavy chain 9606
557 6WJ0 2 L Fab 54-4H03 light chain 9606
558 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
559 4KTE 2 L GE148 Light Chain Fab 9544
560 5I8O 1 H HMM5 antibody heavy chain 9606
561 5I8O 2 L HMM5 antibody light chain 9606
562 4OUO 1 A anti Bla g 1 scFv 9031
563 4JG0 1 L Fab light chain 9606
564 4JG0 2 H Fab heavy chain 9606
565 6LKT 1 A antibody Fab fragment H chain 10090
566 6LKT 2 B antibody Fab Fragment L-chain 10090
567 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
568 4YGV 2 B, L aDabi-Fab2a light chain 9606
569 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
570 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
571 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
572 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
573 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
574 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
575 3EO0 1 A, C GC-1008 Fab Light Chain 10090
576 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
577 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
578 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
579 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
580 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
581 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
582 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
583 6TCO 1 A, L Omalizumab Fab Leu158Pro light chain mutant Omalizumab Fab Leu158Pro light chain mutant 9606
584 6TCO 2 B, H Omalizumab Fab Leu158Pro light chain mutant Omalizumab Fab heavy chain 9606
585 4FQI 3 H antibody CR9114 heavy chain Fab 9606
586 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
587 6KX1 1 A Fab Fragment-SN-101-Heavy chain 10090
588 6KX1 2 B Fab Fragment-SN-101-Light chain 10090
589 6S5A 2 H anti P329G LALA Fab heavy chain 10090
590 6S5A 3 L anti P329G LALA Fab light chain 10090
591 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
592 4JHA 2 L D25 light chain 9606
593 6SS5 1 HHH Fab C0020187 heavy chain (IgG1) Amino acids are numbered according to the Kabat numbering scheme. 9606
594 6SS5 2 LLL Fab C0020187 light chain (IgG1) Amino acids are numbered according to the Kabat numbering scheme. Residue 10 would not be present in the Kabat scheme, but due to problems with non-continuous numbering in L-peptides, we included it. Therefore, residues 2-10 should be read as 1-9, per Kabat. 9606
595 6B9Z 1 A Trastuzumab Fab light chain 10090
596 6B9Z 2 B Trastuzumab Fab heavy chain CSO is partially oxidized cysteine 10090
597 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
598 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
599 4PTT 1 A Antibody pn132p2C05, light chain 9606
600 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
601 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
602 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
603 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
604 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
605 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
606 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
607 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
608 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
609 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
610 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
611 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
612 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
613 4DGV 1 H HCV1 Heavy Chain Fab 9606
614 4DGV 2 L HCV1 Light Chain 9606
615 6C5K 1 A, H IgG1 Fab Heavy Chain 10090
616 6C5K 2 B, L IgG1 Fab Light Chain (Kappa) 10090
617 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
618 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
619 5TH2 1 A, C cetuximab Fab, light chain 10090
620 5TH2 2 B, D cetuximab Fab, heavy chain 10090
621 5I8K 1 L HHH1 Fab Light chain 9606
622 5I8K 2 H HHH1 Fab Heavy chain 9606
623 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
624 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
625 6ULF 1 A 4498 Fab heavy chain 9606
626 6ULF 2 B 4498 Fab light chain 9606
627 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
628 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
629 1YNL 1 L Ig gamma light chain 10090
630 1YNL 2 H Ig gamma heavy chain 10090
631 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
632 5EPM 2 B, F Antibody Fab fragment light chain 10090
633 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
634 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
635 3UMT 1 A scFv heavy chain and light chain 10090
636 6U8D 2 H Heavy chain of Fab HCV2 Heavy chain of Fab HCV2 9606
637 6U8D 3 L Light chain of Fab HCV2 Light chain of Fab HCV2 9606
638 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
639 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
640 6UC5 1 H Fab397 heavy chain 9606
641 6UC5 2 L Fab397 light chain 9606
642 6PEC 1 L antibody light chain 9544
643 6PEC 2 H antibody heavy chain 9544
644 6VJT 1 H Heavy Chain Fab Fragment of Monoclonal Ab15 9606
645 6VJT 2 L Light Chain Fab Fragment of Monoclonal antibody A15 9606
646 4NUJ 1 A PGT152 light chain 9606
647 4NUJ 2 B PGT152 heavy chain 9606
648 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
649 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
650 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
651 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
652 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
653 3U2S 2 B, L PG9 light chain 9606
654 6PE7 1 H FAB Heavy Chain 9606
655 6PE7 2 L FAB Light chain 9606
656 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
657 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
658 6KS2 1 A, C Fab7881 Light Chain (FabL) 10090
659 6KS2 2 B, D Fab7881 Heavy Chain (FabH) 10090
660 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
661 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
662 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
663 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
664 4NUG 1 L PGT151 light chain 9606
665 4NUG 2 H PGT151 heavy chain 9606
666 7BZ5 2 H Heavy chain of B38 9606
667 7BZ5 3 L Light chain of B38 9606
668 3IU4 1 H chP3 Fab heavy chain 10090
669 3IU4 2 L chP3 Fab light chain 10090
670 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
671 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
672 6WYT 1 H MuSK1B heavy chain Fab 9606
673 6WYT 2 L MuSK1B light chain Fab 9606
674 6DC8 1 L IgG light chain 10090
675 6DC8 2 H IgG heavy chain 10090
676 6NYQ 1 L 1H3 Fab light chain 10090
677 6NYQ 2 H 1H3 Fab heavy chain 10090
678 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
679 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
680 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
681 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
682 6IAS 1 H Fab NKp46-1 heavy chain 32630
683 6IAS 2 L Fab NKp46-1 light chain 32630
684 1P7K 1 A, L antibody light chain FAB 10090
685 1P7K 2 B, H antibody heavy chain FAB 10090
686 6WYR 1 L, M MuSK1A light chain Fab 9606
687 6WYR 2 H, I MuSK1A heavy chain Fab 9606
688 6OBZ 1 A, H Heavy chain of FluA-20 Fab 9606
689 6OBZ 2 B, L Light chain of FluA-20 Fab, Immunoglobulin light chain 9606
690 3RVV 2 C 4C1 - light chain 10090
691 3RVV 3 D 4C1 - heavy chain 10090
692 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
693 6GFE 2 L, M Immunoglobulin gamma-4 light chain 9606
694 3P0Y 2 H Fab DL11 heavy chain 9606
695 3P0Y 3 L Fab DL11 light chain 9606
696 4NPY 1 A, L germline PGT121 light chain Fab 9606
697 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
698 6ANA 2 H LL2 Fab Heavy Chain 10090
699 6ANA 3 L LL2 Fab Light Chain 10090
700 5IBU 1 B, L 6652 Light Chain 9606
701 5IBU 2 G, H 6652 Heavy Chain 9606
702 5VPL 2 C 4C1 - LIGHT CHAIN 10090
703 5VPL 3 D 4C1 - HEAVY CHAIN 10090
704 6AOD 1 A FXIa Antibody FAB Light Chain 9606
705 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
706 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
707 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
708 2YPV 2 H FAB 12C1 10090
709 2YPV 3 L FAB 12C1 10090
710 6TCM 1 L Omalizumab Fab Omalizumab Fab light chain 9606
711 6TCM 2 H Omalizumab Fab Omalizumab Fab heavy chain 9606
712 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
713 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
714 4JY5 1 L PGT122 light chain Fab 9606
715 4JY5 2 H PGT122 heavy chain Fab 9606
716 6ELE 1 A, H fAB heavy chain 9606
717 6ELE 2 B, L fAB light chain 9606
718 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
719 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
720 6B5R 1 H CIS42 Fab Heavy chain 9606
721 6B5R 2 L CIS42 Fab Light chain 9606
722 3NAC 1 L Fab15 Mut7 light chain 9606
723 3NAC 2 H Fab15 Mut7 heavy chain 9606
724 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
725 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
726 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
727 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
728 1Q72 1 L Fab M82G2, Light chain 10090
729 1Q72 2 H Fab M82G2, Heavy chain 10090
730 6XCA 1 H C105 Heavy Chain 9606
731 6XCA 2 L C105 Light Chain 9606
732 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
733 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
734 6MNQ 2 H Ab DH727.2 heavy chain Fab fragment 9544
735 6MNQ 3 L Ab DH727.2 light chain 9544
736 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
737 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
738 4YHO 1 H aDabi-Fab3 heavy chain 9606
739 4YHO 2 L aDabi-Fab3 light chain 9606
740 6FZR 1 H scFv-SM3 Special processing instructions: Although this structure is a ScFv, please follow the same numbering as shown in PDB entry 5OWP. 10090
741 6NMT 1 A Fab 3 anti-SIRP-alpha antibody Variable Light Chain 9606
742 6NMT 2 B Fab 3 anti-SIRP-alpha antibody Variable Heavy Chain 9606
743 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
744 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
745 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
746 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
747 4DGY 1 H HCV1 Heavy Chain Fab 9606
748 4DGY 2 L HCV1 Light Chain 9606
749 5EN2 1 A GD01 heavy chain 10090
750 5EN2 2 B GD01 light chain 10090
751 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
752 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
753 6P4Y 1 H 4A10 Fab heavy chain 10090
754 6P4Y 2 L 4A10 Fab light chain 10090
755 3MXW 2 L 5E1 light chain 9606
756 3MXW 3 H 5E1 heavy chain 9606
757 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
758 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
759 3EO9 1 L Efalizumab Fab fragment, light chain 9606
760 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
761 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
762 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
763 6N35 1 K, L Fab 2G12 light chain 9606
764 6N35 2 H, M Fab 2G12 heavy chain 9606
765 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
766 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
767 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
768 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
769 5WUV 1 L light chain 9606
770 5WUV 2 H heavy chain 9606
771 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
772 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
773 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
774 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
775 4JM4 1 H PGT 135 Heavy Chain Fab 9606
776 4JM4 2 L PGT 135 Light Chain Fab 9606
777 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
778 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
779 5YE4 1 A, C 1A9D7 VH CH1 chain 10090
780 5YE4 2 B, D 1A9D7 L chain 10090
781 6B0G 1 C 1245 Antibody, Light Chain 9606
782 6B0G 2 D 1245 Antibody, Heavy Chain 9606
783 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
784 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
785 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
786 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
787 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
788 6BAH 2 B Trastuzumab Fab heavy chain,IGH@ protein 10090
789 6D0X 1 A 2140 Antibody, heavy chain 9606
790 6D0X 2 B 1210 Antibody, light chain 9606
791 6UUD 1 H 5D5 Antibody Fab, heavy chain 10090
792 6UUD 2 L 5D5 Antibody Fab, light chain 10090
793 6BE4 1 H Fab (F598) Heavy Chain 9606
794 6BE4 2 L Fab(F598) Light Chain 9606
795 5TPP 1 L DH270.5 Fab heavy chain 9606
796 5TPP 2 H DH270.5 Fab light chain 9606
797 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
798 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
799 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
800 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
801 6P7H 1 B Antibody DF2F-b.04 light chain 9479
802 6P7H 2 A Antibody DF2F-b.04 heavy chain 9479
803 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
804 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
805 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
806 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
807 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
808 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
809 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
810 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
811 5TL5 1 L M2177 LIGHT CHAIN 10090
812 5TL5 2 H M2177 HEAVY CHAIN 10090
813 2FX7 1 L Fab 4E10 Light Chain 9606
814 2FX7 2 H Fab 4E10 Heavy Chain 9606
815 6O39 1 A Antibody F2.I Fab, Light chain 9606
816 6O39 2 B Antibody F2.I Fab, Heavy chain 9606
817 5Y9K 1 L belimumab light chain 9606
818 5Y9K 2 H belimumab heavy chain 9606
819 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
820 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606
821 5CSZ 1 A, H GANTENERUMAB FAB FRAGMENT HEAVY CHAIN FAB 9606
822 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
823 6GLW 2 C, H Fab 1D11 - Heavy chain 9844
824 6GLW 3 D, L Fab 1D11 - Light chain 9844
825 3WFH 1 A mAb Fab H fragment 10090
826 3WFH 2 B mAb Fab L fragment 10090
827 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913
828 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913
829 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
830 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
831 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
832 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
833 6WFZ 1 A, H Fab399 heavy chain 9606
834 6WFZ 2 B, L Fab399 light chain 9606
835 6GKU 2 H Fab 6F5 - Heavy Chain 9844
836 6GKU 3 L Fab 6F5 - Light chain 9844
837 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
838 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
839 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
840 5VPG 3 D FAB 4C1 - HEAVY CHAIN 10090
841 5HI4 2 C, H CAT-2000 FAB heavy chain 9606
842 5HI4 3 D, L CAT-2000 FAB light chain 9606
843 5NUZ 1 A, H eOD01 heavy chain Fab fragment (domains: variable heavy and constant heavy 1) Fab fragment (domains: variable heavy and constant heavy 1) 10090
844 5NUZ 2 B, L eOD01 light chain Fab fragment (domains: variable light and constant light) Fab fragment (domains: variable light and constant light) 10090
845 6QKD 1 H, I, J, K FAB HEAVY CHAIN 9844
846 6QKD 2 L, M, O, T FAB LIGHT CHAIN 9844
847 5FCU 2 H JR4 FAB HEAVY CHAIN 9544
848 5FCU 3 L JR4 FAB LIGHT CHAIN 9544
849 3RVW 2 C 4C1 - light chain 10090
850 3RVW 3 D 4C1 - heavy chain 10090
851 5DD3 1 H ANTI-HIV ANTIBODY DH570.4 FAB HEAVY CHAIN 9544
852 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
853 5XKU 2 B HNIgGA6 light chain 9606
854 5XKU 3 C HNIgGA6 heavy chain 9606
855 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
856 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606
857 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090
858 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
859 5HI5 2 C, H CAT-2000 FAB heavy chain 9606
860 5HI5 3 D, L CAT-2000 light chain 9606
861 5JO5 1 A, C, E, H 10E8 gHV 9606
862 5JO5 2 B, D, F, L 10E8 gLV 9606
863 5L9D 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN 10090
864 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
865 5CCK 1 H Antibody 3BC315 Fab heavy chain 9606
866 5CCK 2 L Antibody 3BC315 Fab light chain 9606
867 6GXX 1 H FAB 1D9 heavy chain 10090
868 6GXX 2 L FAB 1D9 light chain 10090
869 6JP7 1 H immunoglobulin Fab heavy chain 9606
870 6JP7 2 L immunoglobulin Fab light chain 9606
871 5I76 1 A, C FM318_light_chain 1383439
872 5I76 2 B, D FM318_heavy_cahin 1383439
873 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
874 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090
875 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
876 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
877 6MTT 1 L Antibody VRC46.01 Fb light chain 9606
878 6MTT 2 H Antibody VRC46.01 Fab heavy chain 9606
879 5I18 1 L FAB LIGHT CHAIN 9606
880 5I18 2 H FAB HEAVY CHAIN 9606
881 6QB3 2 X scFv55 9606
882 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090
883 4JN1 2 L anti-dabigatran Fab1, light chain 10090
884 6UGS 1 A, H Infliximab (Remicade) Fab Heavy Chain 9606
885 6UGS 2 B, L Infliximab (Remicade) Fab Light Chain 9606
886 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090
887 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
888 4G5Z 1 H canakinumab antibody fragment heavy chain 9606
889 4G5Z 2 L canakinumab antibody fragment light chain 9606
890 6W00 2 L Fab239 light chain 9606
891 6W00 3 H Fab239 heavy chain 9606
892 6HKG 1 A FISW84 Fab Fragment Heavy Chain 9606
893 6HKG 2 B FISW84 Fab Fragment Light Chain 9606
894 6HKG 3 C FISW84 Fab Fragment Heavy Chain 9606
895 6SF6 1 A, H COMP-reactive monoclonal antibody 15A Fab fragment, heavy chain 10090
896 6SF6 2 B, L COMP-reactive monoclonal antibody 15A Fab fragment, light chain 10090
897 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606
898 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606
899 2OK0 2 L Fab ED10 light chain 10090
900 2OK0 3 H Fab ED10 heavy chain 10090
901 6P4C 1 L HyHEL10 Fab light chain 10090
902 6P4C 2 H HyHEL10 Fab heavy chain 10090
903 3SOB 1 L antibody light chain 9606
904 3SOB 3 H antibody heavy chain 9606
905 6UG8 1 L ch28/11 Fab light chain 10090
906 6UG8 2 H ch28/11 Fab heavy chain 10090
907 6B5M 1 H CIS43 Fab Heavy chain 9606
908 6B5M 2 L CIS43 Fab Light chain 9606
909 5AWN 1 H Heavy chain of 3BC176 Fab 9606
910 5AWN 2 L Light chain of 3BC176 Fab 9606
911 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
912 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090
913 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
914 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090
915 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
916 5DR5 1 H AbD09097 Fab heavy chain The Fab heavy chain contains a C-terminal Myc- and hexahistidine extension preceded by thrombin peptidase recognition sequence to facilitate detection and purification 9606
917 5DR5 2 L AbD09097 Fab light chain 9606
918 6MG5 1 A, B Light chain JTO 9606
919 2IH3 1 A FAB Heavy Chain 10090
920 2IH3 2 B FAB Light Chain 10090
921 4KQ3 1 L CNTO3186 light chain Fab 9606
922 4KQ3 2 H CNTO3186 heavy chain Fab 9606
923 6AQ7 2 H POM6 FAB Heavy CHAIN 10090
924 6AQ7 3 L POM6 FAB light CHAIN 10090
925 4JFX 1 A, L Fab light chain 9606
926 4JFX 2 B, H Fab heavy chain 9606
927 3SGE 1 I, L Light Chain 10090
928 3SGE 2 H, J Heavy Chain 10090
929 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090
930 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090
931 4TUJ 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
932 4TUJ 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
933 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
934 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
935 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606
936 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606
937 5FHB 1 H Antibody 100 Fab heavy chain 9606
938 5FHB 2 L Antibody 100 Fab light chain 9606
939 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090
940 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090
941 1JGU 1 L Antibody Light Chain 10090
942 1JGU 2 H Antibody Heavy Chain 10090
943 4I77 1 H Lebrikizumab heavy chain Fab 9606
944 4I77 2 L Lebrikizumab light chain Fab 9606
945 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606
946 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606
947 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986
948 4O4Y 2 H 2095-2 heavy chain 9986
949 5OBF 1 H fAb Heavy chain 10090
950 5OBF 2